{"id":"CHEMBL1059","canonicalSmiles":"CC(C)C[C@H](CN)CC(=O)O","inchiKey":"AYXYPKUFHZROOJ-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREGABALIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alzain","Axalid","Lecaent","Lyrica","Lyrica cr","Pregabalin","Rewisca"],"synonyms":["CI-1008","NSC-759256","PD-144723","Pregabalin","Pregabalin mylan","Pregabalin sandoz","Pregabalin sandoz gmbh","Pregabalin zentiva","Vronogabic","YNP-1807"],"crossReferences":{"DailyMed":["pregabalin"],"PubChem":["144205028"],"Wikipedia":["Pregabalin"],"drugbank":["DB00230"],"chEBI":["64356"]},"linkedTargets":{"rows":["ENSG00000153956"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0041052","HP_0012735","EFO_0000555","MONDO_0002959","EFO_1001919","EFO_1000657","EFO_0003768","EFO_0004698","HP_0002018","MONDO_0004892","EFO_0003931","EFO_0004263","EFO_0000182","EFO_0004616","EFO_0006510","HP_0003419","EFO_1000789","HP_0008419","EFO_0000400","EFO_0005762","EFO_1001931","EFO_1000877","HP_0012532","EFO_0002687","EFO_1000906","HP_0002027","EFO_0000731","EFO_0003830","EFO_0000342","EFO_0003108","MONDO_0005090","EFO_1001998","EFO_0005687","HP_0000726","MONDO_0007254","EFO_0009846","EFO_0002950","EFO_0007191","EFO_0009562","EFO_1000783","MONDO_0005277","EFO_0000474","EFO_0009430","MONDO_0002050","EFO_0003100","EFO_0004257","MONDO_0007079","EFO_0000707","EFO_0005230","EFO_0004242","EFO_0007490","HP_0002069","EFO_0007493","EFO_0009558","EFO_1001884","HP_0001250","EFO_0003843","HP_0002315","EFO_1001892","EFO_0003890","EFO_0004273","EFO_1000781","EFO_0005611","EFO_0004149","EFO_0004270","MONDO_0005178"],"count":67},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 6 approved and 45 investigational indications."}
{"id":"CHEMBL1095","canonicalSmiles":"CCN1C(=O)NC(c2ccccc2)C1=O","inchiKey":"SZQIFWWUIBRPBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOTOIN","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Peganone"],"synonyms":["Accenon","Ethotoin","NSC-760074"],"crossReferences":{"DailyMed":["ethotoin"],"PubChem":["144203934","56463534"],"Wikipedia":["Ethotoin"],"drugbank":["DB00754"],"chEBI":["4888"]},"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000474","HP_0001250"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for seizure and epilepsy."}
{"id":"CHEMBL109962","canonicalSmiles":"N[C@@H](C[SeH])C(=O)O","inchiKey":"ZKZBPNGNEQAJSX-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENOCYSTEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Selenocysteine"],"drugbank":["DB02345"],"chEBI":["16633"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1109","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1","inchiKey":"QWCJHSGMANYXCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAPHENAZOLE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orisulf","Sulfabid"],"synonyms":["NSC-757859","Sulfafenazol","Sulfaphenazole","Sulphaphenazole"],"crossReferences":{"PubChem":["11111774","11111775","144203813","170465185","26732624","26747662","46500353","50106998"],"Wikipedia":["Sulfaphenazole"],"drugbank":["DB06729"],"chEBI":["77780"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for bacterial disease and eye infection."}
{"id":"CHEMBL1160619","canonicalSmiles":"Cc1cn([C@H]2C[C@H](F)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"GGCAVPJXJISBOA-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160619","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03195"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200354","canonicalSmiles":"CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-].[Na+]","inchiKey":"FVEFRICMTUKAML-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM TETRADECYL SULFATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201345","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fibro-vein","Fibrovein","S.t.d.","Sotradecol"],"synonyms":["NSC-755887","Sodium tetradecyl sulfate","Sodium tetradecyl sulphate"],"crossReferences":{"DailyMed":["sodium%20tetradecyl%20sulfate"],"PubChem":["144205953","144207090","144211872"],"Wikipedia":["Sodium_tetradecyl_sulfate"],"drugbank":["DB00464"],"chEBI":["75273"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and is indicated for varicose veins and has 1 investigational indication."}
{"id":"CHEMBL1200365","canonicalSmiles":"Nc1ccc(C(=O)NCC(=O)[O-])cc1.[Na+]","inchiKey":"UNZMYCAEMNVPHX-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOHIPPURATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL463","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aminohippurate sodium"],"synonyms":[".rho.-aminohippuric acid sodium salt","Aminohippurate sodium","Monosodium p-aminohippurate","P-aminohippurate","P-aminohippurate sodium","Para-aminohippurate sodium [injection]","Sodium p-aminohippurate"],"crossReferences":{"chEBI":["31204"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200464","canonicalSmiles":"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N.Cl","inchiKey":"BFUUJUGQJUTPAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPARACAINE HYDROCHLORIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1196","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alcaine","Kainair","Ophthaine","Ophthetic","Paracaine","Proparacaine hydrochloride"],"synonyms":["Ak-taine","NSC-759896","Proparacaine hcl","Proparacaine hydrochloride","Proxymetacaine","Proxymetacaine hydrochloride"],"crossReferences":{"DailyMed":["proparacaine%20hydrochloride"],"PubChem":["144207096","170465400","56320661"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["HP_0009926"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1200556","canonicalSmiles":"CC(=O)O.N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"MLSVJHOYXJGGTR-IFHOVBQLSA-N","drugType":"Protein","blackBoxWarning":true,"name":"DESMOPRESSIN ACETATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1429","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Concentraid","Ddavp","Ddavp (needs no refrigeration)","Desmomelt","Desmopressin acetate","Desmopressin acetate (needs no refrigeration)","Desmopressin acetate preservative free","Desmospray","Desmotabs","Minirin","Nocdurna","Noctiva","Nocutil","Noqdirna","Octim","Octostim","Presinex","Stimate","Stimate (needs no refrigeration)"],"synonyms":["Anhydrous desmopressin acetate","Desmopressin acetate","Desmopressin acetate anhydrous","Desmopressin acetate hydrate","Desmopressin acetate trihydrate"],"crossReferences":{"DailyMed":["desmopressin%20acetate"]},"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148","ENSG00000198049"],"count":3},"linkedDiseases":{"rows":["MP_0001914","HP_0031364","EFO_0009505","MONDO_0004782","MONDO_0024290","MONDO_0005180","MONDO_0024574","HP_0000863","EFO_0005669","Orphanet_98878","HP_0001742","EFO_1002048"],"count":12},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 7 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200645","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OP(=O)(O)O","inchiKey":"LIQODXNTTZAGID-OCBXBXKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOPOSIDE PHOSPHATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Etopophos","Etopophos preservative free"],"synonyms":["BMY 40481","BMY-40481","Etoposide phosphate","VP-16","VP16","Vepeside"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0004708","MONDO_0100342","EFO_0005952","MONDO_0002087","MONDO_0003541","EFO_0000565","MONDO_0002158","EFO_0000096","MONDO_0008903","EFO_0002918","EFO_0000183","EFO_0000094","EFO_1000158","EFO_0000616","EFO_0000220","MONDO_0008170","EFO_0000403","EFO_0000222","EFO_0002939","EFO_1001946","EFO_0002500","EFO_0000313","EFO_0002501","EFO_0000621","EFO_0008524","EFO_0000702","EFO_0000574","EFO_1001947","EFO_0001378"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved and 20 investigational indications."}
{"id":"CHEMBL1200705","canonicalSmiles":"Br.CC(N)Cc1ccc(O)cc1","inchiKey":"RZCJLMTXBMNRAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYAMPHETAMINE HYDROBROMIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1546","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paredrine"],"synonyms":["Hydroxyamfetamine hbr","Hydroxyamfetamine hydrobromide","Hydroxyamphetamine hbr","Hydroxyamphetamine hydrobromide","Hyroxyamfetamine hydrobromide","NSC-61065","Oxamphetamine hydrobromide","Phenol, 4-(2-aminopropyl)-, hbr"],"crossReferences":{"DailyMed":["hydroxyamphetamine%20hydrobromide"],"PubChem":["124752968","124752971","144205040","26749172"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969."}
{"id":"CHEMBL1200839","canonicalSmiles":"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"MIKKOBKEXMRYFQ-WZTVWXICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIATRIZOATE MEGLUMINE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201220","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angiovist 282","Cardiografin","Cystografin","Cystografin dilute","Diatrizoate meglumine","Hypaque","Hypaque-cysto","Reno","Reno-30","Reno-60","Reno-dip","Urovist cysto","Urovist cysto pediatric","Urovist meglumine diu/ct"],"synonyms":["Diatrizoate meglumine","Diatrizoate methylglucamine","Diatrizoic acid meglumine salt","Meglumine amidotrizoate","Meglumine amidotrizoate injection","Meglumine diatrizoate"],"crossReferences":{"DailyMed":["diatrizoate%20meglumine"],"DrugCentral":["4208"],"PubChem":["8139881"],"chEBI":["31812"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200841","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1.Cl","inchiKey":"HCBIBCJNVBAKAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCAINE HYDROCHLORIDE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL569","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novocain","Pasconeural n","Procaine hydrochloride"],"synonyms":["Anestil","Enpro","Jenacaine","Medaject","NSC-757280","Naucaine","Neocaine","Omnicain","Planocaine","Procaine hcl","Procaine hydrochloride","Procaini hydrochloridum","Rocain","SP-01A","SP01A","Sp01a","Syntocain"],"crossReferences":{"PubChem":["144203799","144212431","170464937","50085977","50106847"],"chEBI":["8431"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and has 1 investigational indication."}
{"id":"CHEMBL1201039","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O","inchiKey":"NDTSRXAMMQDVSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZTHIAZIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquatag","Benzthiazide","Exna","Fovane","Urese"],"synonyms":["Benzothiazide","Benzthiazide","NSC-755902"],"crossReferences":{"PubChem":["11112238","124882104","144203938","170465246","26747882","855918"],"Wikipedia":["Benzthiazide"],"drugbank":["DB00562"],"chEBI":["3047"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201199","canonicalSmiles":"CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"GFIJNRVAKGFPGQ-LIJARHBVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LEUPROLIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-leuprolide","ABBOTT-43818 FREE BASE","CKD-841","Leuporelin","Leuprolide","Leuprorelin","Leuprorelin slow release","NSC-377526","TAP-144 FREE BASE"],"crossReferences":{"DailyMed":["leuprolide%20acetate"],"Wikipedia":["Leuprorelin"],"drugbank":["DB00007"],"chEBI":["6427"]},"childChemblIds":["CHEMBL1200775","CHEMBL4802223"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0001382","EFO_0004248","EFO_1000256","EFO_0005204","EFO_0003869","Orphanet_64739","EFO_0001065","EFO_0009006","EFO_0000756","MONDO_0003061","MONDO_0007254","EFO_1001469","HP_0031217","EFO_0002950","HP_0100543","MONDO_0002146","MONDO_0000088","EFO_0000673","EFO_0000196","EFO_0000183","EFO_0000616","EFO_0000545","MONDO_0019165","EFO_0001073","EFO_0003843","MONDO_0008315","EFO_0000660","EFO_0001663","EFO_0000537","EFO_0000311","HP_0004322","EFO_0009029","EFO_0000731","EFO_0000764","MONDO_0004975","EFO_0001378","MONDO_0024880","EFO_0003922"],"count":38},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 7 approved and 28 investigational indications."}
{"id":"CHEMBL1201335","canonicalSmiles":"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1","inchiKey":"ANGKOCUUWGHLCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOPYRRONIUM","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Glycopyrrolate cation","Glycopyrrolate ion","Glycopyrronium","Glycopyrronium cation","Glycopyrronium ion","Glycopyrronium, erythro-"],"crossReferences":{"DailyMed":["glycopyrrolate","glycopyrronium%20tosylate"],"Wikipedia":["Glycopyrronium_bromide"],"drugbank":["DB00986"]},"childChemblIds":["CHEMBL3707243","CHEMBL1201027"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004210","EFO_0004269","EFO_0009512","EFO_0001645","EFO_0009516","EFO_0009267","MONDO_0001187","HP_0002110","EFO_0007149","HP_0006536","MONDO_0002050","EFO_0010282","MONDO_0100096","MONDO_0004247","EFO_0006505","EFO_0004888","EFO_1000632","MONDO_0004979","HP_0000975","EFO_0000341","HP_0002307","GO_0007596","EFO_0005251"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 8 approved and 10 investigational indications."}
{"id":"CHEMBL1201546","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PURIFIED BEEF","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lente iletin ii"],"synonyms":["Insulin zinc susp purified beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL1201561","drugType":"Protein","blackBoxWarning":true,"name":"PEGINTERFERON ALFA-2B","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Peg-Intron","Pegintron"],"synonyms":["Peg-interferon alfa-2b","Pegifn alfa-2b","Peginterferon alfa-2b","Peginterferon-alfa-2b","Pegylated interferon alpha 2b","Sylatron"],"crossReferences":{"DrugCentral":["5164"],"Wikipedia":["Peginterferon_alfa-2b"]},"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_1000403","EFO_0000637","MONDO_0019471","EFO_0000756","EFO_0000681","EFO_1000209","EFO_1001469","MONDO_0002087","EFO_0007304","MONDO_0016691","EFO_0000565","EFO_0002430","HP_0000083","MONDO_0002158","EFO_0000339","MONDO_0002974","EFO_0000389","EFO_0000182","EFO_0000326","EFO_0003047","EFO_0000707","EFO_0002617","EFO_0000479","HP_0012115","EFO_0000616","EFO_0000765","EFO_0006859","EFO_0001642","MONDO_0008170","EFO_0000180","Orphanet_636","EFO_0004197","EFO_0004243","EFO_0002429","EFO_0005221","EFO_0004239","EFO_0009708","EFO_0000311","EFO_0001422","EFO_0004220","MONDO_0100096","EFO_0000658","EFO_0009259","EFO_0000764","EFO_0000574","MONDO_0002367","EFO_0001378","MONDO_0018079"],"count":48},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 38 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201593","drugType":"Enzyme","blackBoxWarning":false,"name":"ALTEPLASE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actilyse","Actilyse cathflo","Activase","Cathflo activase"],"synonyms":["Alteplase","Alteplase (genetical recombination)","Alteplase for injection","Alteplase, recombinant","Alteplase,recombinant","Ec 3.4.21.68","RT-PA","Tissue plasminogen activator alteplase"],"crossReferences":{"DailyMed":["alteplase"],"DrugCentral":["5141"]},"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0009680","EFO_0003086","EFO_0003097","EFO_1001154","MONDO_0002679","EFO_0005669","MONDO_0001370","EFO_0000373","EFO_1000637","MONDO_0020673","EFO_0003913","EFO_0003966","EFO_0008585","EFO_1001375","EFO_0000544","EFO_0003144","EFO_0000712","MONDO_0005299","HP_0004419","MONDO_0002037","EFO_0003030","EFO_0000616","EFO_0000694","HP_0000016","HP_0002140","EFO_0009661","EFO_1001157","EFO_0000618","EFO_1001753","EFO_1001045","EFO_0000311","MP_0001914","EFO_0000713","MONDO_0100096","MONDO_0000831","EFO_0003827","EFO_0003907","EFO_0008583","EFO_0000612","EFO_0009637","HP_0004418"],"count":41},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 8 approved and 24 investigational indications."}
{"id":"CHEMBL1201610","drugType":"Protein","blackBoxWarning":false,"name":"CORTICOTROPIN","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acth","Acthar","Acthar gel","Adrenocorticotropic Hormone","Adrenocorticotropin","Adrenomone","Corticotropin","Cortigel","Cortrophin","H.p. acthar gel","Purified cortrophin gel"],"synonyms":["Corticotropin","Corticotropin, repository","Repository corticotropin"],"linkedTargets":{"rows":["ENSG00000185231"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0007405","EFO_0000401","DOID_13406","EFO_0003778","MONDO_0002462","EFO_1000637","EFO_1001129","MONDO_0001718","MONDO_0005277","EFO_0000474","EFO_0004254","EFO_0002690","Orphanet_3451","EFO_0003884","EFO_0004255","MONDO_0004976","EFO_0008522","HP_0030895","Orphanet_797","EFO_0000685","EFO_0005761","EFO_0009449","EFO_1000906","HP_0000093","EFO_0003929","EFO_0004236","EFO_0009538","EFO_0000660","EFO_0000621","EFO_1001119","EFO_1001231","EFO_1000986","MONDO_0005301","EFO_0000398","EFO_0008520","EFO_0000557"],"count":37},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for multiple sclerosis and west syndrome and has 21 investigational indications."}
{"id":"CHEMBL1213165","canonicalSmiles":"C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N21.[Na+]","inchiKey":"UGWJRRXTMKRYNK-VSLILLSYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLUTEGRAVIR SODIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1229211","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tivicay","Tivicay pd"],"synonyms":["Dolutegravir sodium","Dolutegravir sodium salt","Dovato","GSK-1349572A","GSK1349572","GSK1349572A"],"crossReferences":{"DailyMed":["dolutegravir%20sodium"],"Wikipedia":["Dolutegravir"],"chEBI":["76007"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for hiv-1 infection and hiv infection."}
{"id":"CHEMBL1223","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+]","inchiKey":"IYNDLOXRXUOGIU-LQDWTQKMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN G POTASSIUM","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cilloral","Liquapen","Penicillin","Penicillin g potassium","Penicillin-2","Pentids","Pentids '200'","Pentids '250'","Pentids '400'","Pentids '800'","Pfizerpen","Pfizerpen g","Scotcil"],"synonyms":["Benzylpenicillin potassium","E705","NSC-131815","Penicillin G Potassium","Penicillin g potassium","Penicillin g potassium salt","Penicillin potassium g, crystalline","Penicillin-2","Pfizerpen","Pfizerpen G"],"crossReferences":{"DailyMed":["penicillin%20g%20potassium"],"PubChem":["56422871","855606"],"chEBI":["7963"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and has 11 investigational indications."}
{"id":"CHEMBL1231055","canonicalSmiles":"CC(C)CCCCCCCCC(=O)N(C)[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)Cc2ccc(O)c(c2)-c2cc1ccc2O","inchiKey":"YFSXYWAZCKMYJN-JBBOGOJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARYLOMYCIN A2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arylomycin A2"],"crossReferences":{"drugbank":["DB01934"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231491","canonicalSmiles":"C[N+](C)(C)CC=O","inchiKey":"SXKNCCSPZDCRFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAINE ALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110846","90341389"],"drugbank":["DB04401"],"chEBI":["15710"]},"childChemblIds":["CHEMBL1256576"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233147","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"XKMLYUALXHKNFT-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOSINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GTP","Guanosine Triphosphate"],"crossReferences":{"PubChem":["26756682"],"drugbank":["DB04137"],"chEBI":["15996"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235380","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(N)(=O)=O)cc4CC[C@H]3[C@@H]1CC(=O)N(Cc1cccnc1)C2=O","inchiKey":"LSJKARAMQNGZDF-YOEKFXIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235380","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08418"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235902","canonicalSmiles":"CCCCc1nc(N)[se]c1CCC","inchiKey":"DOUUMUUUWUAPPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235902","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01740"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123693","canonicalSmiles":"CCCCCC(C)N","inchiKey":"VSRBKQFNFZQRBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUAMINOHEPTANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-1091","Tuaminoheptane"],"crossReferences":{"Wikipedia":["Tuaminoheptane"],"drugbank":["DB13238"]},"childChemblIds":["CHEMBL1368028","CHEMBL3560769"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1240967","canonicalSmiles":"CC(C)(Cc1cccc(CC(=O)NCc2cccc(-c3ccc(O)cc3)c2)c1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1","inchiKey":"YPHDIMUXXABSSO-YTTGMZPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00610355","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF - 00610355","PF-610355","Pf-00610355"],"crossReferences":{"drugbank":["DB11871"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341","EFO_0003818"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL126279","canonicalSmiles":"CCNC(C)Cc1ccc2c(c1)OCO2","inchiKey":"PVXVWWANJIWJOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126279","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01566"]},"childChemblIds":["CHEMBL3187218"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1272307","canonicalSmiles":"Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1","inchiKey":"ZJXIUGNEAIHSBI-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-649868","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK649868","SB-649868","Sb-649868"],"crossReferences":{"Wikipedia":["SB-649,868"],"drugbank":["DB14822"]},"childChemblIds":["CHEMBL3527302"],"linkedTargets":{"rows":["ENSG00000137252","ENSG00000121764"],"count":2},"linkedDiseases":{"rows":["EFO_0008568","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL14021","canonicalSmiles":"CCC(=O)O","inchiKey":"XBDQKXXYIPTUBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIONIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antischim b","E-280","E280","Ethanecarboxylic acid","FEMA NO. 2924","INS NO.280","INS-280","Luprosil","Metacetonic acid","Propanoic acid","Propionate","Propionic acid"],"crossReferences":{"PubChem":["251919690"],"Wikipedia":["Propanoic_acid"],"drugbank":["DB03766"],"chEBI":["30768"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL146032","canonicalSmiles":"CC(=O)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C(F)(F)C(F)(F)F)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1","inchiKey":"VHZPUDNSVGRVMB-RXDLHWJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LONAPRISAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY86-5044","Lonaprisan","ZK 230211","ZK-230211","Zk-230211"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1474889","canonicalSmiles":"CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1","inchiKey":"KVHHQGIIZCJATJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOBUTINOL","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"],"year":2007},"tradeNames":[],"synonyms":["Clobutinol","Clobutinol hydrochloride","Iversal","KAT 256 [AS HYDROCHLORIDE]","R05DB03"],"crossReferences":{"PubChem":["29215379"],"drugbank":["DB09004"]},"childChemblIds":["CHEMBL3183114"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and is indicated for cough. It was withdrawn in European Union  in 2007 due to Cardiotoxicity."}
{"id":"CHEMBL1484857","canonicalSmiles":"O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1","inchiKey":"SKVLYVHULOWXTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINYLSULFATHIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Succinylsulfathiazole"],"crossReferences":{"PubChem":["11112259","144203951","170465721","855781"],"drugbank":["DB13580"],"chEBI":["9309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1500276","canonicalSmiles":"CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1","inchiKey":"IQADUMSPOQKAAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXELADIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxeladin","Oxeladin citrate","Oxeladin tannate"],"crossReferences":{"PubChem":["26660767"],"Wikipedia":["Oxeladin"],"drugbank":["DB04822"]},"childChemblIds":["CHEMBL2354637"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1588","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.[Cl-]","inchiKey":"MYVIATVLJGTBFV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1547","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaxin","Vitamin B 1"],"synonyms":["Aneurine","Apatate drape","Beivon","Betamin","Bethiamin","Oryzanin","Thiacoat","Thiamin","Thiamine","Thiamine (vit b1)","Thiamine monochloride","Vitamin b-1","Vitaneurin"],"crossReferences":{"PubChem":["50085978"],"Wikipedia":["Thiamine"],"chEBI":["33283"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved indications."}
{"id":"CHEMBL1650619","canonicalSmiles":"On1ccccc1=S","inchiKey":"YBBJKCMMCRQZMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHIONE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-179790","Omadine"],"crossReferences":{"chEBI":["36578"]},"childChemblIds":["CHEMBL3392049","CHEMBL2105351"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL1743032","drugType":"Antibody","blackBoxWarning":false,"name":"INTETUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNTO 095","CNTO 95","CNTO-095","CNTO-95","Intetumumab"],"linkedTargets":{"rows":["ENSG00000138448"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000673"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743068","drugType":"Antibody","blackBoxWarning":false,"name":"SECUKINUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AIN-457","AIN457","AIN457A","Cosentyx","Secukinumab"],"crossReferences":{"DailyMed":["secukinumab"],"DrugCentral":["4934"]},"linkedTargets":{"rows":["ENSG00000112115"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","EFO_1000710","EFO_0003780","MONDO_0019269","EFO_0003778","EFO_0000274","EFO_0000540","EFO_0008518","EFO_0000676","HP_0000999","EFO_0000685","EFO_0005761","EFO_1000906","EFO_1001466","EFO_0003898","EFO_0003929","MONDO_0019558","EFO_0000384","EFO_1001209","EFO_1000760","EFO_1001231","MP_0001845","EFO_0004192","EFO_1000738","MONDO_0005301","Orphanet_2897","MONDO_0005147","MONDO_0004979","EFO_0000706","MONDO_0005178","EFO_1001434","EFO_0009856"],"count":32},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 5 approved and 24 investigational indications."}
{"id":"CHEMBL178130","canonicalSmiles":"CCc1cc(-c2n[nH]c(C(=O)O)c2-c2ccc3c(c2)OCO3)c(O)cc1O","inchiKey":"LCTWZJKHOGKNMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL178130","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02840"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1834657","canonicalSmiles":"CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O","inchiKey":"GUQNHCGYHLSITB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INFIGRATINIB PHOSPHATE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1852688","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Truseltiq"],"synonyms":["BGJ-398 phosphate","Infigratinib monophosphate","Infigratinib phosphate"],"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0005221"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for cholangiocarcinoma."}
{"id":"CHEMBL192894","canonicalSmiles":"COc1ccc(-c2c(-c3ccc(O)cc3O)n[nH]c2C)cc1","inchiKey":"GSBFARPNIZUMHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL192894","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137276075"],"drugbank":["DB08356"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105801","canonicalSmiles":"CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O.Cl","inchiKey":"KXNZMBFOWDNCRU-QVMZSJACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELGOSIVIR HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110737","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Celgosivir hcl","Celgosivir hydrochloride","MDL 28,574A","MDL-28574A"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106068","canonicalSmiles":"CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1.Cl","inchiKey":"IJFUJIFSUKPWCZ-SQMFDTLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRASENTAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL9194","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-127722","A-147627.1","ABBOT-147627","ABT-627","Atrasentan hcl","Atrasentan hydrochloride"],"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","MONDO_0008170","MONDO_0002367","MONDO_0002087","MONDO_0024880","MONDO_0008315","EFO_1000158"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2107308","canonicalSmiles":"COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC.Cl.O.O.O","inchiKey":"NPTDXIXCQCFGKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOTIAMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2107723","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acotiamide hydrochloride","Acotiamide hydrochloride hydrate","Acotiamide hydrochloride trihydrate","YM-443","YM443","Z-338"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0008533"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107358","canonicalSmiles":"COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\\c1[nH]c(C)cc1C.CS(=O)(=O)O","inchiKey":"ZFKXDVMHNXPEIY-PEZBNFGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBATOCLAX MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL408194","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GX-15-070MS","GX15-070MS","Obatoclax","Obatoclax mesilate","Obatoclax mesylate"],"linkedTargets":{"rows":["ENSG00000140379","ENSG00000171552","ENSG00000258643","ENSG00000171791","ENSG00000137875","ENSG00000143384","ENSG00000129473"],"count":7},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0044903","MONDO_0001023","EFO_0000095","EFO_0001642","MONDO_0008903","EFO_0000403","EFO_0000702","EFO_0001378","EFO_1001469","MONDO_0018906","EFO_0000183","EFO_0002617"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL2107465","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCNC[C@@H]1OC","inchiKey":"OMLDMGPCWMBPAN-YPMHNXCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICALOPRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naronapride metabolite m4","Ticalopride"],"crossReferences":{"drugbank":["DB06422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107576","canonicalSmiles":"CNCCON=c1c2ccccc2ccc2ccccc12","inchiKey":"SEDQWOMFMIJKCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMEXIPTILINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demexiptiline"],"crossReferences":{"drugbank":["DB08998"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108074","drugType":"Enzyme","blackBoxWarning":false,"name":"PANCRELIPASE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accelerase","Cotazym","Cotazym-s","Creon","Entolase","Ilozyme","Ku-zyme hp","Pancrease","Viokase","Zymase"],"synonyms":["Lipancreatin","Pancrelipase","Pancrelipase (amylase;lipase;protease)"],"crossReferences":{"DailyMed":["pancrelipase%20(amylase;lipase;protease)"],"DrugCentral":["5161"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 investigational indications."}
{"id":"CHEMBL2108200","drugType":"Unknown","blackBoxWarning":false,"name":"DIMETHICONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conotrane","Cymex","Hedrin","Johnson's","Rikospray","Sentry dimethicone","Sentry dimethicone dispension","Siopel","Sprilon","Superderm","Vasogen"],"synonyms":["Dimethicone","Dimethicone 360","Dimethicone medical fluid 360","Dimethicones","Dimethyl polysiloxane","Dimethylpolysiloxane","Dimethylsilicone fluid","Dimeticone","Dimeticone ","Dimeticone-360","E-900A","INS NO.900A","INS-900A","Poly(dimethylsiloxane)","Polydimethylsiloxane","Silkonoel ak 500"],"crossReferences":{"DrugCentral":["3152"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 6 approved and 1 investigational indication."}
{"id":"CHEMBL2108201","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTRANOMER","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Debrisan"],"synonyms":["Debrisorb","Dextranomer"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for skin ulcer."}
{"id":"CHEMBL2108221","drugType":"Unknown","blackBoxWarning":false,"name":"ALOE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aloe","Aloe barbadensis miller leaf","Aloe capensis leaf","Aloe ferox miller leaf","Aloe leaf","Aloe leaf inspiccated juice","Aloe leaf juice","Aloe leaf latex","Aloe socotrina","Aloe, unspecified","Aloes","Aloes-","B2348"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2108535","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYNOXYLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anaflex"],"synonyms":["Formaldehyde, urea polymer","Gabrite","Hygromull","Karbamol","Kauresin k244","Kaurit 420","Oxymethylene urea","Pianizol","Piatherm","Plastopal bt","Polynoxylin","Ponoxylan","Resamin 155f","Uformite 700","Urea-formaldehyde resin","Ureaform"],"crossReferences":{"DrugCentral":["4693"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL2108607","drugType":"Enzyme","blackBoxWarning":false,"name":"HYALURONIDASE (OVINE)","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Diffusin","Enzodase","Hyazyme","Vitrase","Wydase"],"synonyms":["HYO-6A","HYO6A","Hyaluronidase (ovine)","Hyaluronidase, ovine"],"description":"Enzyme drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108730","drugType":"Antibody","blackBoxWarning":true,"name":"SARILUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kevzara"],"synonyms":["REG-N88","REGN-88","REGN88","SAR-153191","SAR153191","Sarilumab"],"crossReferences":{"DailyMed":["sarilumab"]},"linkedTargets":{"rows":["ENSG00000160712"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","EFO_0000685","EFO_0003898","MONDO_0016586","EFO_0000540","EFO_0002609","EFO_0000311","EFO_0003106","EFO_1001209","EFO_1001231","EFO_0008518","MONDO_0100096","EFO_1001361","EFO_0007328"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for immune system disease and rheumatoid arthritis and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108778","drugType":"Unknown","blackBoxWarning":false,"name":"POLIOVIRUS VACCINE LIVE ORAL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Orimune"],"synonyms":["Poliovirus vaccine live oral"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109103","drugType":"Antibody","blackBoxWarning":false,"name":"BERTILIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bertilimumab","CAT-213","ICO-008"],"linkedTargets":{"rows":["ENSG00000172156"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0007187"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109257","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-1C11","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-1C11"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109264","drugType":"Antibody","blackBoxWarning":false,"name":"SOLITOMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MT110","Solitomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL216697","canonicalSmiles":"CN(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N3CCOCC3)nc2)cc1","inchiKey":"AINVOEOJEKKMKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216697","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL229128","canonicalSmiles":"Cc1ccccc1OCC(O)CO","inchiKey":"JWDYCNIAQWPBHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENESIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decontractyl","Tolserol"],"synonyms":["Cresoxydiol","Mephenesin","NSC-25234"],"crossReferences":{"PubChem":["144204909","170466586","26748509"],"Wikipedia":["Mephenesin"],"drugbank":["DB13583"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2355051","canonicalSmiles":"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1","inchiKey":"GKIRPKYJQBWNGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMIPHENE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clomifene","Clomiphene"],"crossReferences":{"DailyMed":["clomiphene%20citrate"],"PubChem":["144206661","170464951"],"drugbank":["DB00882"],"chEBI":["3752"]},"childChemblIds":["CHEMBL3185958"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MP_0001914","MONDO_0002146","EFO_0000545","EFO_1001485","EFO_0000512","EFO_0000731","EFO_0000279","EFO_0008560","MONDO_0002775","EFO_0001073","EFO_0000660","MONDO_0018555","EFO_0002950"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 3 approved and 12 investigational indications."}
{"id":"CHEMBL24038","canonicalSmiles":"CCO[C@@H](Cc1ccc(OCCN2c3ccccc3Oc3ccccc32)cc1)C(=O)O","inchiKey":"WMUIIGVAWPWQAW-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAGAGLITAZAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ragaglitazar"],"crossReferences":{"drugbank":["DB07675"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL240719","canonicalSmiles":"Cc1ccccc1CC(=O)Nc1cc(C)c(S(=O)(=O)NCC(=O)O)c(C)c1","inchiKey":"CJKKMQCZOLCXAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL240719","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01689"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24231","canonicalSmiles":"O=[N+]([O-])c1ccc(OP(=O)(O)O)cc1","inchiKey":"XZKIHKMTEMTJQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"p-NITROPHENYLPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Nitrophenyl Dihydrogen Phosphate","4-Nitrophenyl Phosphate","P-Nitrophenylphosphate"],"crossReferences":{"Wikipedia":["Para-Nitrophenylphosphate"],"drugbank":["DB04214"],"chEBI":["17440"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL256705","canonicalSmiles":"C[C@@H]1CC(=O)c2c(ccc3c2C(=O)c2cccc(O)c2C3=O)C1","inchiKey":"ZAWXOCUFQSQDJS-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCHROMYCINONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J655.169F","Ochromycinone","STA-21"],"crossReferences":{"drugbank":["DB15644"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL261244","canonicalSmiles":"CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21.[Na+].[Na+]","inchiKey":"MKQKPLQMNCXTJE-VEZQGTPESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"REGRELOR DISODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1162175","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INS-50589","INS50589","Regrelor disodium"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL267744","canonicalSmiles":"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl","inchiKey":"AGHANLSBXUWXTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICRYNAFEN","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," France"],"classes":["Hepatotoxicity"],"year":1980},"tradeNames":["Selacryn"],"synonyms":["SK&F 62698","Ticrynafen","Tienilic acid"],"crossReferences":{"PubChem":["144205234","144205235","29215401","29215402"],"Wikipedia":["Tienilic_acid"],"drugbank":["DB04831"],"chEBI":["9590"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for cardiovascular disease. It was withdrawn in United Kingdom,  United States,  Germany and  France initially in 1980 due to Hepatotoxicity."}
{"id":"CHEMBL267777","canonicalSmiles":"Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"JUQLTPCYUFPYKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tiserton"],"synonyms":["NSC-758470","R 55,667","R-55667","Ritanserin"],"crossReferences":{"PubChem":["11111716","144203802","170466554","50100336","50104035","50104036","50104037","50123110","56423112","85231205","855736","90340705"],"drugbank":["DB12693"],"chEBI":["64195"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL286204","canonicalSmiles":"O=C(O)c1cccnc1C(=O)O","inchiKey":"GJAWHXHKYYXBSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyridine-2,3-Dicarboxylic Acid","Quinolinic Acid"],"crossReferences":{"PubChem":["11111698","11113416","124881252","144212368","26747101","50104349","57260132","90341105"],"Wikipedia":["Quinolinic_acid"],"drugbank":["DB01796"],"chEBI":["16675"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL290578","canonicalSmiles":"CC(C)OC(=O)Nc1ccc2[nH]c(-c3cscn3)nc2c1","inchiKey":"QZWHWHNCPFEXLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Camdan"],"synonyms":["Cambendazole","Camvet","NSC-377071"],"crossReferences":{"PubChem":["144206277","50125821"],"drugbank":["DB11380"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295467","canonicalSmiles":"CNCCC(Oc1ccccc1OC)c1ccccc1","inchiKey":"ITJNARMNRKSWTA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NISOXETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COMPOUND 89218","LY-94939","NSC-283481","Nisoxetine"],"crossReferences":{"PubChem":["104171195","144203754","170466483","26752034","50104694","90341689"],"Wikipedia":["Nisoxetine"],"drugbank":["DB09186"],"chEBI":["73410"]},"childChemblIds":["CHEMBL1628648","CHEMBL1256695"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30424","canonicalSmiles":"Cc1cccc2nc3cccc(C(=O)NCCNCCNCCNC(=O)c4cccc5nc6cccc(C)c6nc45)c3nc12","inchiKey":"SFOADSRLCHRTKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL30424","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06364"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137310","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341.Cl","inchiKey":"VVCUIDHKAHHSAN-JJHQWJQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZHYDROCODONE HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3137321","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzhydrocodone hydrochloride","KP-201","KP201"],"crossReferences":{"DailyMed":["benzhydrocodone%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003890","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for pain and drug dependence."}
{"id":"CHEMBL3137338","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ASVASIRAN SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALN-RSV-01","ALN-RSV01","Asvasiran sodium"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL318516","canonicalSmiles":"NCCCCCCNCCCCCCN","inchiKey":"MRNZSTMRDWRNNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL318516","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207244"],"drugbank":["DB04684"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186761","canonicalSmiles":"CC(=O)O[C@@H]1C[C@@H]2CC[C@@]1(C)C2(C)C","inchiKey":"KGEKLUUHTZCSIP-HOSYDEDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186761","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205151","144212050"],"drugbank":["DB14665"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186849","canonicalSmiles":"O=C(O)CCCCC(CCSCc1ccccc1)SCc1ccccc1","inchiKey":"ZYRLHJIMTROTBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPI 613","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPI 613","Cpi 613","Cpi-613","Devimistat"],"crossReferences":{"PubChem":["174007465"],"drugbank":["DB12109"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3544917","canonicalSmiles":"C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O","inchiKey":"GIBQQARAXHVEGD-BSOLPCOYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RAPASTINEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GLYX-13","Rapastinel","Rapastinelum","Tppt-amide"],"crossReferences":{"drugbank":["DB11801"]},"linkedTargets":{"rows":["ENSG00000161509","ENSG00000183454","ENSG00000116032","ENSG00000273079","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0004242"],"count":2},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545135","drugType":"Small molecule","blackBoxWarning":false,"name":"NV-128","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nv-128"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545314","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(N)=O)C(C)C","inchiKey":"ZUJBBVJXXYRPFS-DYKIIFRCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DUSQUETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arg-ile-val-pro-ala-nh2","Dusquetide","IMX-942","SGX-94","SGX-942","SGX94","SGX942","Sgx942"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545355","canonicalSmiles":"COc1ccc(C2=C(Cc3ccc(OCCN4CCCCC4)cc3)c3ccc(O)cc3OC2)cc1","inchiKey":"ZUDXUNPSRMREOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHF4227","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chf4227"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545431","drugType":"Small molecule","blackBoxWarning":false,"name":"HMN-214","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hmn-214","IVX-214"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707231","canonicalSmiles":"C[C@]12C[C@H](Cl)[C@@]3(Cl)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO","inchiKey":"VTWKPILBIUBMDS-OTJLYDAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUCLOROLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluclorolone"],"crossReferences":{"drugbank":["DB13856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707338","canonicalSmiles":"Cc1ncc(COP(=O)([O-])O)c(C=O)c1O.NC(=O)CC[C@H](N)C(=O)[O-].[Mg+2]","inchiKey":"HFAKVRNAKYBCSN-RJXKWAGSSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM PYRIDOXAL 5-PHOSPHATE GLUTAMATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707339","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium pyridoxal 5-phosphate glutamate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL38912","canonicalSmiles":"C[C@@H](NC(=O)c1cc(F)ccc1O)c1ccc(Br)cc1","inchiKey":"KFTNEILVDDUXGR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL38912","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02880"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3984441","canonicalSmiles":"Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C","inchiKey":"VQYYQSZNRVQLIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NINGETINIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-053 FREE BASE","CT-053-PTSA FREE BASE","CT053PTSA FREE BASE","Ningetinib"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000167601","ENSG00000105976","ENSG00000122025","ENSG00000153208"],"count":5},"linkedDiseases":{"rows":["EFO_0000182"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989563","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1.O.O.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"LDMPZNTVIGIREC-CZEDPBFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE BITARTRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-97238","Nicotine (as bitartrate)","Nicotine acid tartrate dihydrate","Nicotine bitartrate","Nicotine bitartrate anhydrous","Nicotine bitartrate dihydrate","Nicotine hydrogen-l-tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3989869","canonicalSmiles":"CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"KYJWUPZPSXZEPG-NTISSMGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UMBRALISIB TOSYLATE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3948730","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ukoniq"],"synonyms":["RP-5307","TGR-1202","TGR-1202 (4-METHYLBENZENESULFONATE)","Tgr-1202","Umbralisib tosylate"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000097007","ENSG00000213923"],"count":3},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0044903","Orphanet_44890","EFO_1000657","EFO_0000403","MONDO_0007576","EFO_1001469","EFO_0002429","EFO_1001951","EFO_0000211","MONDO_0001056","EFO_0000095","EFO_1000630","MONDO_0018906","EFO_0000183"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for marginal zone b-cell lymphoma and follicular lymphoma and has 13 investigational indications."}
{"id":"CHEMBL3989954","canonicalSmiles":"C=C1CC[C@H]2[C@H](CN)[C@@H]([C@@]3(C)CC[C@H](O)C[C@@H]3CO)CC[C@]12C","inchiKey":"MDEJTPWQNNMAQF-BVMLLJBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSIPTOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AQX-1125","AQX-1125 free base","Aqx-1125","Rosiptor"],"crossReferences":{"drugbank":["DB13012"]},"childChemblIds":["CHEMBL3989953"],"linkedTargets":{"rows":["ENSG00000168918"],"count":1},"linkedDiseases":{"rows":["EFO_0008507","EFO_1000869","EFO_0000341","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3990014","drugType":"Antibody","blackBoxWarning":false,"name":"MIRIKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3074828","LY3074828","Mirikizumab"],"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000676","EFO_0000384"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL399530","canonicalSmiles":"CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O","inchiKey":"OWPMENVYXDJDOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CCT018159","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCT018159"],"crossReferences":{"PubChem":["103905505","174006740","26755036"],"drugbank":["DB07594"],"chEBI":["41656"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406652","canonicalSmiles":"O=C(O)c1cccc2c(-c3ccccc3)c(-c3ccccc3)[nH]c12","inchiKey":"OLUDUXWVPIEHDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406652","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24819975"],"drugbank":["DB08709"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL421","canonicalSmiles":"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O","inchiKey":"NCEXYHBECQHGNR-QZQOTICOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFASALAZINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azulfidine","Azulfidine EN","Azulfidine en-tabs","Colizine","S.a.s.","S.a.s.-500","Salazopyrin","Salazopyrin e.c.","Salazopyrin-en","Salazosulfapyridine","Salicylazosulfapyridine","Sulfasalazine","Ucine"],"synonyms":["Azulfidine","Benzosulfa","NSC-203730","NSC-667219","SAS-500","Salazosulfapyridine","Salicylazosulfapyridine","Sulfasalazine","Sulfasalazinum","Sulfasalazopyridine","Sulphasalazine"],"crossReferences":{"DailyMed":["sulfasalazine"],"PubChem":["144204588","144208437","144210859","170464716","17389737","26747277"],"TG-GATEs":["34"],"Wikipedia":["Sulfasalazine"],"drugbank":["DB00795"],"chEBI":["9334"]},"childChemblIds":["CHEMBL3765414","CHEMBL2311115"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000012779","ENSG00000095303"],"count":3},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","EFO_0001361","EFO_0004268","EFO_0006911","EFO_0003898","EFO_0003778","EFO_0004149","EFO_0003102","HP_0004798","MONDO_0004565","EFO_0002609","EFO_0000519"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL4250860","canonicalSmiles":"CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(-c3cnc(C)nc3)cc12","inchiKey":"PIBARDGJJAGJAJ-NQIIRXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANICOPAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACH-0144471","ACH-4471","Ach-0144471","Danicopan"],"crossReferences":{"drugbank":["DB15401"]},"linkedTargets":{"rows":["ENSG00000197766"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","Orphanet_93571","MONDO_0100096","EFO_0001365","EFO_0001421","Orphanet_329931","Orphanet_329903","Orphanet_447"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297226","drugType":"Unknown","blackBoxWarning":false,"name":"CANERPATUREV","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Canerpaturev","HF10","TBI-1401"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297292","canonicalSmiles":"C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1.[Cl-]","inchiKey":"VALRCWBOFWDEDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-17166864","maximumClinicalTrialPhase":2,"parentId":"CHEMBL397647","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-17166864","Jnj-17166864"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297388","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1C(C)(C)C1(C)C)C(=O)OCC#N","inchiKey":"WUBKGTSFJSEIEM-NSHBDUGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW-870086","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW870086","GW870086X","Gw-870086","Gw870086x"],"crossReferences":{"drugbank":["DB12322"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297448","canonicalSmiles":"c1ccc(-c2cc(-c3ccncc3)c(N3CCN(c4ncccn4)CC3)nn2)cc1","inchiKey":"ZPJGUEPHFXPAQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TT-301","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MW-01-6-189WH","MW-189","MW01-6-189WH","TT301","Tt-301","Tt301"],"crossReferences":{"drugbank":["DB12899"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297506","canonicalSmiles":"FC(F)(F)c1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1","inchiKey":"FUAHXHWSMYFWGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPACONAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dapaconazole"],"crossReferences":{"drugbank":["DB11985"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297619","canonicalSmiles":"O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12","inchiKey":"NALAUGMPMIVAOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENARODUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enarodustat","JTZ-951","Jtz-951"],"crossReferences":{"drugbank":["DB14985"]},"childChemblIds":["CHEMBL4166742"],"linkedTargets":{"rows":["ENSG00000135766"],"count":1},"linkedDiseases":{"rows":["EFO_0003884"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297633","canonicalSmiles":"CC(C)OC(=O)CCC[C@H]1CC[C@H]2[C@H](C[C@@H](O)[C@@H]2/C=C/[C@@H](O)COc2cc(F)ccc2F)OC1","inchiKey":"BKVUSNOUTQMSBE-XCMGCKIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEPETAPROST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DE-126","ONO-9054","Ono-9054","Sepetaprost"],"crossReferences":{"drugbank":["DB12043"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297636","canonicalSmiles":"C/C=C\\C[C@@H](C/C=C\\NC(=O)[C@@H](NC(=O)/C=C\\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O","inchiKey":"IEKGSKLKBICCHQ-BDOJOPHNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLOCABULIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.348.355D","PM-060184","PM060184","Plocabulin","Pm 060184","Pm060184"],"crossReferences":{"drugbank":["DB13137"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297861","drugType":"Antibody","blackBoxWarning":false,"name":"NEIHULIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abgn-168h","Neihulizumab"],"linkedTargets":{"rows":["ENSG00000110876"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000729","EFO_0003778","EFO_0000676","EFO_0004599"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297878","drugType":"Antibody","blackBoxWarning":false,"name":"LIRENTELIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-002","AK002","Ak-002","Ak002","Antolimab","Lirentelimab","Monoclonal antibody ak002"],"linkedTargets":{"rows":["ENSG00000105366"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","EFO_0005531","MONDO_0016586","EFO_0007141","EFO_0000274","MONDO_0004627"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298014","drugType":"Unknown","blackBoxWarning":false,"name":"LSZ-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LSZ-102","LSZ102","Lsz-102","Lsz102"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298169","canonicalSmiles":"O=C(O)c1cc(F)c2nc(N3[C@H]4CC[C@@H]3C[C@H](OCc3c(-c5ccccc5OC(F)(F)F)noc3C3CC3)C4)sc2c1","inchiKey":"VYLOOGHLKSNNEK-PIIMJCKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPIFEXOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LJN-452","LJN452","NVP-LJN452-NXA","Tropifexor"],"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","EFO_1001249","EFO_1001486"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL430879","canonicalSmiles":"N#Cc1ccc(N(Cc2ccc(OS(N)(=O)=O)cc2)n2cnnc2)cc1","inchiKey":"WEXGHQDVDVWOIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL430879","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04601"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL431770","canonicalSmiles":"CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O","inchiKey":"IQVRBWUUXZMOPW-PKNBQFBNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISTRADEFYLLINE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nourianz"],"synonyms":["Istradefylline","KW-6002","Nouriast"],"crossReferences":{"DailyMed":["istradefylline"],"PubChem":["170466116"],"Wikipedia":["Istradefylline"],"drugbank":["DB11757"]},"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","MONDO_0005180","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for parkinson disease and has 2 investigational indications."}
{"id":"CHEMBL4459585","canonicalSmiles":"Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1","inchiKey":"XPLZTJWZDBFWDE-OYOVHJISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROPSACITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06826647","Pf-06826647","Ropsacitinib"],"linkedTargets":{"rows":["ENSG00000105397"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000710","EFO_0000676"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL455271","canonicalSmiles":"NS(=O)(=O)c1ccc2[nH]c(-c3cscn3)nc2c1","inchiKey":"KGMVTZZDGKDTEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL455271","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594310","drugType":"Antibody","blackBoxWarning":false,"name":"NIPOCALIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-281","M281","Nipocalimab"],"linkedTargets":{"rows":["ENSG00000104870"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005761","EFO_0002690","EFO_1001264","EFO_0004991","EFO_0000699"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4594392","drugType":"Antibody","blackBoxWarning":false,"name":"SERCLUTAMAB TALIRINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-321","ABBV-321 TALIRINE","Abbv-321","Serclutamab talirine"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594491","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"REMLARSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MRG-201","Mrg-201","Remlarsen"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594532","drugType":"Antibody","blackBoxWarning":false,"name":"AVIZAKIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avizakimab","BOS-161721","BOS161721","Bos161721"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594539","drugType":"Unknown","blackBoxWarning":false,"name":"BOTULINUM TOXIN TYPE E","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bontoxilysin-e","Botulinum neurotoxin type e","Botulinum toxin type e","EB-001","Eb-001"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650238","drugType":"Gene","blackBoxWarning":false,"name":"LETETRESGENE AUTOLEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-3377794","GSK3377794","Letetresgene autoleucel"],"description":"Gene drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802136","canonicalSmiles":"NC(=O)Nc1cc(C#Cc2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1","inchiKey":"ULVAGWVTXBTFRN-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHI-101","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PHI-101","PHI101","Phi-101"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802181","drugType":"Unknown","blackBoxWarning":false,"name":"STI-6643","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["STI-6643","Sti-6643"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL506569","canonicalSmiles":"CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"JAYAGJDXJIDEKI-PTGWOZRBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANATOSIDE C","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cedilanid"],"synonyms":["Allocor","Celadigal","Cetosanol","Digilanogen c","Isolanid","Isolanide","Lanatigen c","Lanatoside c","Lanatoside c jp 17","Lanimerck","NSC-119991","NSC-7533"],"crossReferences":{"PubChem":["144204914"],"Wikipedia":["Lanatoside_C"],"drugbank":["DB13467"]},"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000105409","ENSG00000132681"],"count":4},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL509282","canonicalSmiles":"C=CCC(C(=O)NC(N)=O)C(C)C","inchiKey":"KSUUMAWCGDNLFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRONAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apronal","Apronalide","Sedormid"],"crossReferences":{"Wikipedia":["Apronal"],"drugbank":["DB13221"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL542","canonicalSmiles":"Nc1ccc(C(=O)O)cc1","inchiKey":"ALYNCZNDIQEVRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOBENZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rvpaba lipstick"],"synonyms":["4-Aminobenzoic Acid","4-aminobenzoate","Aminobenzoic Acid","Aminobenzoic acid","Benzoic acid, 4-amino","NSC-7627","P-aminobenzoic acid","Paba","Para-aminobenzoic acid"],"crossReferences":{"PubChem":["144204620","144208900","170466660","17388804","47193723","73461"],"Wikipedia":["4-Aminobenzoic_acid"],"drugbank":["DB02362"],"chEBI":["30753"]},"childChemblIds":["CHEMBL1564391","CHEMBL1437781","CHEMBL1762658"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL558722","canonicalSmiles":"Clc1cc(Cl)c2c(c1)CCc1ccccc1C2n1ccnc1","inchiKey":"MPTJIDOGFUQSQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EBERCONAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eberconazole"],"crossReferences":{"drugbank":["DB13656"],"chEBI":["83584"]},"childChemblIds":["CHEMBL4534605"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL575060","canonicalSmiles":"N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"WHUUTDBJXJRKMK-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTAMIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E 620","E-620","E620","FEMA NO. 3285","Glutamic acid","Glutamic acid, l-","Glutamidex","INS NO.620","INS-620","L-2-amino-pentanedioic acid","L-Glutamate","L-alpha-aminoglutaric acid","L-glutamic acid","NSC-143503"],"crossReferences":{"PubChem":["11113412","144206604","26751652","90340902"],"drugbank":["DB00142"],"chEBI":["16015"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL581","canonicalSmiles":"O=C(O)[C@@H]1C[C@@H](C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCc1ccccc1","inchiKey":"WOIWWYDXDVSWAZ-RTWAWAEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSINOPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosfenopril","Fosinopril diacid","Fosinopril related compound a","Fosinoprilat","Fosinoprilic acid","SO 27,519","SO-27519","SQ 27,519","SQ-27519"],"crossReferences":{"drugbank":["DB14207"],"chEBI":["116962"]},"childChemblIds":["CHEMBL361014"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL71","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21","inchiKey":"ZPEIMTDSQAKGNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORPROMAZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elmarin","Largactil","Megaphen","Thorazine"],"synonyms":["Aminazine","Chlorpromazine","Chlorpromazine hibenzate","Chlorpromazine phenolphthalinate","Chlorpromazine tannate","Chlorpromazinum","Esmind","Fenactil","J2.794D","Largactilothiazine","NSC-167745","NSC-226514","Novomazina","Propaphenin","SKF-2601A","Sanopron","Sonazine","Wintermin"],"crossReferences":{"DailyMed":["chlorpromazine%20hydrochloride"],"PubChem":["104171139","11110990","11110991","124879752","124879754","124879757","144203671","152146164","170465371","26747094","26747095","26751620","26751621","50100209","50104291","57287810","90340916"],"TG-GATEs":["16"],"Wikipedia":["Chlorpromazine"],"drugbank":["DB00477"],"chEBI":["3647"]},"childChemblIds":["CHEMBL1713"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0100096","EFO_0004216","EFO_0000677","HP_0002017","Orphanet_738","EFO_0005407","EFO_0009267","EFO_0005799","EFO_0000519"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 6 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL87","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2","inchiKey":"IAKHMKGGTNLKSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL87","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174007360","26747941","49671357"],"drugbank":["DB01394"],"chEBI":["23359"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93560","canonicalSmiles":"C[C@H](O)[C@@H](CCc1cccc2ccccc12)n1cnc(C(N)=O)c1","inchiKey":"OODDZQQDDOVCFD-SCLBCKFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL93560","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03220"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL96712","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"JINJZWSZQKHCIP-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEU5AC2EN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03991"],"chEBI":["28062"]},"childChemblIds":["CHEMBL3330705"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
